/term/bs-payables-and-accrued-expenses/STU:RYH0 Sareum Holdings (STU:RYH0) Accounts Payable & Accrued Expen
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (STU:RYH0) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

Sareum Holdings (STU:RYH0) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 2021. Start your Free Trial

What is Sareum Holdings Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.

Sareum Holdings (STU:RYH0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (STU:RYH0) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Comparable Companies
LSE:TRX LSE:AREC LSE:OBD LSE:OBI LSE:SBTX LSE:HEMO LSE:ONC LSE:OPTI LSE:NSCI LSE:DEST OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SAR:UK RYH0:Germany
Address
Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Website
http://www.sareum.com
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.